Pharmaceuticals · Technology Transfer
Pharmaceutical Technology Transfer Consulting
The short answer
Technology transfer succeeds or fails on what the receiving site is given: process understanding, not just a batch record. We support sending and receiving organizations through transfer planning, protocol design, analytical method transfer, comparability and the validation work that follows.
01
Why this matters
- Transfers frequently move a process to equipment with different geometry, shear, heat transfer or hold capability — and the parameter ranges do not always survive the move.
- Analytical method transfer is often started too late, so release testing becomes the bottleneck after engineering batches succeed.
- When a transfer goes badly, the cost is not only remediation; it is supply.
02
Applicable regulations and standards
- ICH Q10, Section 3
- Technology transfer as a defined lifecycle stage of the pharmaceutical quality system.
- ICH Q8 / Q11
- Process and control strategy knowledge that must accompany the transfer.
- 21 CFR 211.100
- Production and process control procedures at the receiving site.
- USP <1224>
- Transfer of analytical procedures, including comparative testing approaches.
03
What our consultants actually do
- Build the transfer plan and governance structure across sending unit, receiving unit and quality
- Assemble the knowledge package: development history, control strategy, characterization data, known failure modes
- Perform receiving-site readiness assessment covering equipment, utilities, personnel qualification and quality system capability
- Design engineering and demonstration batch protocols with meaningful acceptance criteria
- Manage analytical method transfer, including comparative studies and laboratory qualification
- Define the comparability strategy and connect transfer outcomes to process validation and regulatory commitments
04
Across the product lifecycle
01 / DEVELOP
Knowledge captured in a form that can actually be transferred.
02 / SCALE
Scale-dependent parameters isolated before site selection.
03 / TRANSFER
Protocols, gap assessment, engineering batches and knowledge sessions.
04 / VALIDATE
PPQ at the receiving site with criteria informed by transfer data.
05 / MANUFACTURE
Early commercial batches monitored more closely than steady state.
06 / MAINTAIN
Post-transfer review, trend comparison against the sending site.
05
Problems we are usually called about
- Batch record transferred without the rationale behind the parameters
- Receiving site quality system not assessed until after engineering batches
- Analytical method transfer started after process transfer, delaying release
- Raw material specifications identical but the supplier or grade quietly different
- No documented comparability conclusion linking pre- and post-transfer product
06
Typical deliverables
- Technology transfer plan and governance model
- Process knowledge and control strategy transfer package
- Receiving site readiness gap assessment
- Transfer and demonstration batch protocols and reports
- Analytical method transfer protocols and comparability summary
07
Frequently asked
- What is the most common cause of a failed technology transfer?
- Transferring documents instead of understanding. When the receiving site does not know why a parameter range exists, it cannot recognise when a scale or equipment difference has invalidated it.
- Does a site transfer always require new process validation?
- In practice, a new manufacturing site generally requires process performance qualification at that site. The extent can be informed by transfer and engineering data, but that justification must be documented.
- Do you support transfers to or from contract manufacturers?
- Yes — both directions, including sponsor-side oversight when the receiving organization runs the execution.
08
References
More for pharmaceuticals
cGMP, validation and manufacturing quality support for drug products.
- Process ValidationProcess validation for a drug product is a three-stage lifecycle: design the process and its control strategy, qualify commercial-scale performance, and then verify that the process stays in control for as long as it is used.
- Cleaning ValidationCleaning validation demonstrates that a documented cleaning procedure consistently reduces residues to scientifically justified limits on shared equipment.
- cGMP ConsultingcGMP consulting for a drug manufacturer means making 21 CFR Parts 210 and 211 operable in your facility — with procedures your staff can follow, records that reconstruct what happened and a quality unit with the authority to act.
- Quality SystemsA pharmaceutical quality system is the set of connected processes — documents, changes, deviations, CAPA, training, release, review — that keep product decisions defensible.
- IND CMC SupportSponsors filing an IND usually need two things at once: CMC content for the application and a quality system capable of overseeing clinical manufacturing.
- NDA Manufacturing SupportThis is the site-side companion to an NDA filing: making sure the validated process, the control strategy and the records at the manufacturing site match what the application says, and that the people there can explain it during a pre-approval inspection..
Start a project
Tell us what you're working on.
Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.